“…This study paints a compelling picture of the intricate interplay between saliva-based monitoring, non-adherence, and optimal carbamazepine therapy for Jordanian epilepsy patients, in contrast to the single approach employed in previously published studies [ 4 , 30 ]. The results of this study serve as guidance for healthcare facilities seeking to use saliva levels for the assessment of medication adherence.…”